Novartis Shows Long-Term Benefits Of Psoriasis Drug Cosentyx In New Set Of Clinical Data

Novartis' new injectable psoriasis drug Cosentyx was shown to act rapidly on psoriatic arthritis. Its efficacy was also sustained over a period of one year.